| 22.4 -0.54 (-2.35%) | 06-03 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 31.28 |
1-year : | 34.48 |
| Resists | First : | 26.78 |
Second : | 29.52 |
| Pivot price | 23.38 |
|||
| Supports | First : | 22.35 |
Second : | 18.59 |
| MAs | MA(5) : | 23.18 |
MA(20) : | 23.74 |
| MA(100) : | 25.8 |
MA(250) : | 22.58  |
|
| MACD | MACD : | -0.8 |
Signal : | -0.8 |
| %K %D | K(14,3) : | 18 |
D(3) : | 26.3 |
| RSI | RSI(14): 30.4 |
|||
| 52-week | High : | 30.42 | Low : | 18.25 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ NVST ] has closed below the lower bollinger band by 14.1%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 63.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 23.15 - 23.31 | 23.31 - 23.44 |
| Low: | 21.94 - 22.15 | 22.15 - 22.32 |
| Close: | 22.1 - 22.39 | 22.39 - 22.62 |
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
Wed, 03 Jun 2026
NVST Stock Explained for 2026 Growth Drivers and Risks - TradingView
Tue, 02 Jun 2026
Here's why Envista (NVST) is a strong value stock - MSN
Tue, 02 Jun 2026
Here's Why Envista (NVST) is a Strong Value Stock - Yahoo Finance
Fri, 22 May 2026
The Bull Case For Envista Holdings (NVST) Could Change Following New Small-Cap Fund Backing And Margin Focus - Yahoo Finance
Thu, 21 May 2026
Envista (NYSE: NVST) director granted 9,330 RSUs vesting in 1 year - Stock Titan
Thu, 21 May 2026
Envista (NYSE: NVST) director Kieran Gallahue receives 9,330-share RSU award - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Equipment & Services
|
|
| Shares Out | 163 (M) |
| Shares Float | 162 (M) |
| Held by Insiders | 0.4 (%) |
| Held by Institutions | 113.2 (%) |
| Shares Short | 11,410 (K) |
| Shares Short P.Month | 11,020 (K) |
| EPS | 0.4 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 18.89 |
| Profit Margin | 2.4 % |
| Operating Margin | 9.8 % |
| Return on Assets (ttm) | 3 % |
| Return on Equity (ttm) | 2.2 % |
| Qtrly Rev. Growth | 14.3 % |
| Gross Profit (p.s.) | 9.52 |
| Sales Per Share | 17.26 |
| EBITDA (p.s.) | 2.35 |
| Qtrly Earnings Growth | 130 % |
| Operating Cash Flow | 272 (M) |
| Levered Free Cash Flow | 216 (M) |
| PE Ratio | 54.63 |
| PEG Ratio | 0 |
| Price to Book value | 1.18 |
| Price to Sales | 1.29 |
| Price to Cash Flow | 13.39 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|